| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/17/2008 | US20080090907 Crystal Comprising (2R)-2-Propyloctanoic Acid and Amine |
| 04/17/2008 | US20080090903 Improved stability via dibasic calcium phosphate dihydrate excipient; tablets; nervous system disorders |
| 04/17/2008 | US20080090902 Improved stability via dibasic calcium phosphate dihydrate excipient; tablets; nervous system disorders |
| 04/17/2008 | US20080090895 Novel Pharmaceutical Composition And Their Uses Thereof For Controlling The Different Forms Of Addiction To Drugs |
| 04/17/2008 | US20080090892 Amorphous asenapine and processes for preparing same |
| 04/17/2008 | US20080090875 Analgesics, antipyretics, antiinflammatory agents; 4-(4-chlorophenyl)-5-(4-methanesulfonylphenyl)-1,2-dihydropyrazole-3-thione for example; cyclooxygenase-2 (COX-2) inhibitors; side effect reduction |
| 04/17/2008 | US20080090872 AMPA and NMDA receptor modulators; depression, epilepsy, schizophrenia, Alzheimer's, disease, learning and memory disorders, and mild cognitive impairment; 5,1',5'-trimethyl-2'-phenyl-1',2'-dihydro-2H-[3,4']bipyrazolyl-3'-one for example |
| 04/17/2008 | US20080090871 Cannabimimetic indole derivatives |
| 04/17/2008 | US20080090864 Compositions of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
| 04/17/2008 | US20080090863 Melanin Concentrating Hormone (MCH) receptor antagonists; eating disorder, obesity, psychological disorders, drug addiction, diabetes, cardiovascular disorders; 2-(cyclohexyl(alkyl)amino)pyridines such as 3-chloro-4-fluoro-N-(cis-4-[(4-methoxypyridin-2-yl)amino]cyclohexyl)benzamide |
| 04/17/2008 | US20080090862 Isoquinoline Derivatives as Calpain Inhibitors |
| 04/17/2008 | US20080090861 Cancer and fibrotic disorders such as scarring prevention; 2-(4-methyl-1-(6-methylpyridin-2-yl)-1H-pyrazol-5-yl)thieno[2,3-c]pyridine for example; activin receptor-like kinase-5 (ALK-5) inhibitors |
| 04/17/2008 | US20080090860 Side effect reduction; 2-carboxy-4-(2-propoxy-3,5-di-tert-butylphenyl)-benzo[b]thiophene for example; syndrome X, non-insulin dependent diabetes mellitus, cancer, photoaging, acne, psoriasis, obesity, cardiovascular disease, atherosclerosis, uterine leiomyomata, inflamatory or neurodegenerative disease |
| 04/17/2008 | US20080090859 For example, N-methyl-N-[(1S)-1-phenyl-2-((3S)-3-hydroxypyrrolidin-1-yl) ethyl]-2,2-diphenylacetamide; for the diagnosis, prophylaxis and or the treatment of neuropathy, the clinical pictures and symptoms associated therewith, and related disorders |
| 04/17/2008 | US20080090858 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 04/17/2008 | US20080090855 Substituted Cyclic Urea Derivatives and the Use Thereof as Vanilloid Receptor 1 Modulators |
| 04/17/2008 | US20080090854 Cxcr2 inhibitors |
| 04/17/2008 | US20080090850 Herpetic neuralgia topical treatment |
| 04/17/2008 | US20080090838 N-Hydroxyamide Derivatives and Use Thereof |
| 04/17/2008 | US20080090835 Polymorphic forms of ziprasidone HCl and processes for their preparation |
| 04/17/2008 | US20080090834 Selective azole pde10a inhibitor compounds |
| 04/17/2008 | US20080090829 5-{2-[2-(4-Tert-Butyl- phenyl)-oxazol-4-yl]-ethylsulfamoyl}-2-methyl-benzoic acid methyl ester; used as peroxisome proliferator activator receptor agonist, to increase high density lipoproteins and lower LDL-cholesterol and triglycerides; treatment of atherosclerosis, cardiovascular, metabolic disorders |
| 04/17/2008 | US20080090827 Compounds With Mixed Pde-Inhibitory and Beta-Adrenergic Antagonist or Partial Agonist Activity For Treatment of Heart Failure |
| 04/17/2008 | US20080090823 Thiadiazoles as cxc- and cc- chemokine receptor ligands |
| 04/17/2008 | US20080090822 Piperazine Derivatives As Glyt 1 Inhibitors |
| 04/17/2008 | US20080090817 Bridged N-Cyclic Sulfonamido Inhibitors of Gamma Secretase |
| 04/17/2008 | US20080090815 Anticoagulates for treating cardiovascular disorders, such as myocardial infarct, angina pectoris, restenoses after angioplasty, bypass, stroke; treatment of atherosclerosis, arthritis, Alzheimer's disease or cancer |
| 04/17/2008 | US20080090810 Thiophene compounds |
| 04/17/2008 | US20080090806 (Calcitonin gene related peptide); azepinone ligands; 1-[(2-methoxyethyl)-2-oxo-6-phenylazepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide; analgesic, antiinflammatory agent; migranes, arthritis, neurodegenerative diseases |
| 04/17/2008 | US20080090805 Cb-1 modulating compounds and their use |
| 04/17/2008 | US20080090803 Fatty alcohol drug conjugates |
| 04/17/2008 | US20080090802 2-[2-(3-Chlorophenyl)-4-oxo-6-perhydro-1,4-diazepin-1-yl-4H-quinazolin-3-yl]-N-isopropylacetamide; hypothalamo-pituitary-adrenal (HPA) axis stress relieving agent; adrenocorticotropic hormone (ACTH)/ glucocorticoid antagonist; psychological and bipolar disorders, schizophrenia, psychosis, hyperactivity |
| 04/17/2008 | US20080090798 Heterocyclic Substituted Aminoazacycles Useful as Central Nervous System Agents |
| 04/17/2008 | US20080090797 tert-Butyl[3-(4-phenyloxazolidin-2-on-3-yl)-4-(2-styryl)azetidin-2-on-1-yl]acetate; known as synthetic intermediates for the preparation of beta -lactam antibiotics; diuretic |
| 04/17/2008 | US20080090796 Useful in the treatment of neurological and psychiatric disorders associated with glutamatergic neurotransmission dysfunction and diseases; schizophrenia; 2,4-dichloro-N-{[4-(cyclopropylmethyl)-1-[(1-methyl-1H-pyrazol-4-yl)sulfonyl]piperidin-4-yl]methyl}benzamide |
| 04/17/2008 | US20080090785 Peptide-based compounds include at least three peptide units, an epoxide or aziridine, and functionalization at the N-terminus inhibit specific activities of N-terminal nucleophile (Ntn) hydrolases, e.g., the chymotrypsin-like activity of the 20S proteasome; antiproliferative and antiinflammatory agents |
| 04/17/2008 | US20080090771 Modification of pharmacokinetic and pharmacological properties of hydrocodone through covalent modification by conjugating hydrocodone with a carrier selected from an amino acid, a dipeptide, a tripeptide, a tetrapeptide and a pentapeptide; analgesic; bioavailability |
| 04/17/2008 | US20080090767 Agent for prophylaxis of reflex sympathetic dystrophy after cerebral apoplexy |
| 04/17/2008 | US20080090756 Somatostatin agonists |
| 04/17/2008 | US20080090755 Follistatin Variant Polypeptide |
| 04/17/2008 | US20080090290 Nucleic Acids Encoding Anti-IL-12 Antibodies, and Methods of Production |
| 04/17/2008 | US20080090270 Neuronal binding protein for use tool in identifying modulators for prevention and treatment of nervous system disorders |
| 04/17/2008 | US20080090260 Peptide sequence for use as substrate in bioassays which monitor aspartyl protease activity |
| 04/17/2008 | US20080089900 Identification of self and non-self antigens implicated in autoimmune disease |
| 04/17/2008 | US20080089897 ActRIIB Fusion Polypeptides and Uses Therefor |
| 04/17/2008 | US20080089863 Non-Integrative And Non-Replicative Lentivirus , Preparation And Uses Thereof |
| 04/17/2008 | US20080089859 Administration of sleep restorative agents |
| 04/17/2008 | US20080089845 optimizing therapeutic efficacy for treatment of anxiety, depression, pain, or a metabolic disorder by increasing or decreasing a dose of a fatty amide ( oleoylethanolamide or palmitoylethanolamide) hydrolase inhibitor according to a patient's fatty amide levels by administering a carbamate derivative |
| 04/17/2008 | CA2683127A1 Treatment of inflammation, demyelination and neuronal/axonal loss |
| 04/17/2008 | CA2672920A1 Aryl piperazine derivatives useful for the treatment of neuropsychiatric disorders |
| 04/17/2008 | CA2666653A1 Polymorph b of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-n-methyl-acetamide |
| 04/17/2008 | CA2666536A1 Compositions and methods of using chondroitinase abci mutants |
| 04/17/2008 | CA2666466A1 Complement inhibition for improved nerve regeneration |
| 04/17/2008 | CA2666143A1 Spiro (furo [3, 2-c] pyridine-3-3 ' -indol) -2' (1'h)-one derivatives and related compounds for the treatment of sodium-channel mediated diseases, such as pain |
| 04/17/2008 | CA2666130A1 Kinase inhibitors |
| 04/17/2008 | CA2666084A1 1-naphthyl alkylpiperidine derivative |
| 04/17/2008 | CA2665573A1 Novel crystal of (s)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate |
| 04/17/2008 | CA2665071A1 N-substituted-azacyclylamines as histamine-3 antagonists |
| 04/17/2008 | CA2664920A1 Thioglucose spiroketal derivative and use thereof as therapeutic agent for diabetes |
| 04/17/2008 | CA2664054A1 An antidepressant comprising a branched amino acid |
| 04/17/2008 | CA2659923A1 Substituted pyrazinone derivatives for use as a medicine |
| 04/17/2008 | CA2652980A1 Robust sustained release formulations of oxymorphone |
| 04/16/2008 | EP1911837A2 FAD4, FAD5, FAD5-2, and FAD6, fatty acid desaturase family members and uses thereof |
| 04/16/2008 | EP1911759A1 Azaindole derivative having pgd2 receptor antagonistic activity |
| 04/16/2008 | EP1911755A1 Benzoimidazole compound capable of inhibiting prostaglandin d synthetase |
| 04/16/2008 | EP1911754A1 Dipeptidyl peptidase inhibitors |
| 04/16/2008 | EP1911743A1 Cyclic amine compound |
| 04/16/2008 | EP1911740A1 Potassium channel modulators |
| 04/16/2008 | EP1911460A1 Pharmaceutical composition for promoting axonal re-growth and behaviour recovery in spinal cord injury |
| 04/16/2008 | EP1911458A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/16/2008 | EP1911456A1 A medicine for abstaining from addiction to drugs and process thereof |
| 04/16/2008 | EP1911446A2 The use of PPAR-gamma agonists for treating diseases characterised by neuron degeneration, neuron injury or impaired plasticity |
| 04/16/2008 | EP1911442A2 Preparation for the prevention and/or treatment of vascular disorders |
| 04/16/2008 | EP1910381A2 Substituted 1-oxa-3,8-diazaspiro[4.5]-decan-2-on- compounds and the use thereof for producing drugs |
| 04/16/2008 | EP1910380A1 Oxazolopyridine derivatives as sirtuin modulators |
| 04/16/2008 | EP1910364A2 Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease |
| 04/16/2008 | EP1910358A2 Heterocyclic janus kinase 3 inhibitors |
| 04/16/2008 | EP1910346A2 Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonist |
| 04/16/2008 | EP1910344A2 Indoline-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 04/16/2008 | EP1910342A1 Multicyclic sulfonamide compounds as inhibitors of histone deacetylase for the treatment of disease |
| 04/16/2008 | EP1910340A1 Indazolecarboxamide derivatives as 5ht4 receptor agonists |
| 04/16/2008 | EP1910339A2 Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 04/16/2008 | EP1910331A1 PYRAZOLE DERIVATIVES AS CBl MODULATORS |
| 04/16/2008 | EP1910325A2 New pharmaceutical compounds |
| 04/16/2008 | EP1910321A1 New compounds, process for their preparation, intermediates, pharmaceutical compositions and their use in the treatment of 5-ht6 mediated disorders such as alzheimer's disease, cognitive disorders, cognitive impairment associated with schizophrenia, obesity and parkinson's disease |
| 04/16/2008 | EP1910316A1 Substituted triazole derivatives and their use as neurokinin 3 receptor antagonists |
| 04/16/2008 | EP1910315A2 Benzodiazepine derivatives, their preparation and the therapeutic use thereof |
| 04/16/2008 | EP1910309A2 CYCLOALKYL AMINO-HYDANTOIN COMPOUNDS AND USE THEREOF FOR ß-SECRETASE MODULATION |
| 04/16/2008 | EP1910301A2 Cycloalkane-substituted pyrazoline derivatives, their preparation and use as medicaments |
| 04/16/2008 | EP1910300A2 Prodrugs of pyrazoline compounds, their preparation and use as medicaments |
| 04/16/2008 | EP1910299A1 Substituted pyrazoline compounds, their preparation and use as medicaments |
| 04/16/2008 | EP1910296A2 4-aryloxy quinoline derivatives as 5-ht6 modulators |
| 04/16/2008 | EP1910292A1 Piperidine derivative as tachykinin receptor antagonist |
| 04/16/2008 | EP1909912A2 Use of collismycin and derivatives thereof as oxidative stress inhibitors |
| 04/16/2008 | EP1909910A1 Benzimidazole derivatives as sirtuin modulators |
| 04/16/2008 | EP1909850A2 Rnai modulation of the rho-a gene and uses thereof |
| 04/16/2008 | EP1909821A2 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders |
| 04/16/2008 | EP1909816A2 Dermonecrotizing protein factors of bacterial origin and related uses in medical field |
| 04/16/2008 | EP1909812A2 Small compounds that correct protein misfolding and uses thereof |
| 04/16/2008 | EP1909804A1 Glucosamine and derivatives thereof useful as tg inhibitors |